Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 687

1.

Retinal vasculature in glaucoma: a review.

Chan KKW, Tang F, Tham CCY, Young AL, Cheung CY.

BMJ Open Ophthalmol. 2017 Jul 11;1(1):e000032. doi: 10.1136/bmjophth-2016-000032. eCollection 2017. Review.

PMID:
29354699
2.

Expression of hepatic progenitor cell markers in acute cellular rejection of liver allografts - an immunohistochemical study.

Lo RC, Chan KK, Leung CO, Ng IO.

Clin Transplant. 2018 Jan 18. doi: 10.1111/ctr.13203. [Epub ahead of print]

PMID:
29345755
3.

The economic burden of cancer care in Canada: a population-based cost study.

de Oliveira C, Weir S, Rangrej J, Krahn MD, Mittmann N, Hoch JS, Chan KKW, Peacock S.

CMAJ Open. 2018 Jan 4;6(1):E1-E10. doi: 10.9778/cmajo.20170144. Epub 2018 Jan 4.

4.

Combined electroacupuncture and auricular acupuncture for postoperative pain after abdominal surgery for gynecological diseases: study protocol for a randomized controlled trial.

Lam WL, Yeung WF, Wong MK, Cheung CW, Chan KKL, Ngan HYS, Wong CKH, Chen HY, Lao L.

Trials. 2018 Jan 4;19(1):8. doi: 10.1186/s13063-017-2359-8.

5.

Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.

Chen K, Liu MX, Mak CS, Yung MM, Leung TH, Xu D, Ngu SF, Chan KK, Yang H, Ngan HY, Chan DW.

Theranostics. 2018 Jan 1;8(2):423-436. doi: 10.7150/thno.22377. eCollection 2018.

6.

A systematic review and network meta-analysis of post-imatinib therapy in advanced gastrointestinal stromal tumour.

Shah K, Chan KKW, Ko YJ.

Curr Oncol. 2017 Dec;24(6):e531-e539. doi: 10.3747/co.24.3463. Epub 2017 Dec 20. Review.

7.

Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013.

Gong IY, Yan AT, Ko DT, Earle CC, Cheung WY, Peacock S, Hall M, Gale CP, Chan KKW.

Cancer. 2017 Dec 6. doi: 10.1002/cncr.31174. [Epub ahead of print]

PMID:
29211307
8.

Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis.

Cheng S, Qureshi M, Pullenayegum E, Haynes A, Chan KK.

ESMO Open. 2017 Sep 21;2(4):e000225. doi: 10.1136/esmoopen-2017-000225. eCollection 2017.

9.

Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?

Cheung MC, Chan KK, Sabharwal M, Fields A, Chambers A, Evans WK.

ESMO Open. 2017 Feb 22;1(6):e000124. doi: 10.1136/esmoopen-2016-000124. eCollection 2016. Review.

10.

A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis.

Abrahao ABK, Ko YJ, Berry S, Chan KKW.

Clin Colorectal Cancer. 2017 Nov 21. pii: S1533-0028(17)30105-6. doi: 10.1016/j.clcc.2017.10.016. [Epub ahead of print]

PMID:
29174481
11.

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.

Zer A, Pond GR, Razak ARA, Tirona K, Gan HK, Chen EX, O'Sullivan B, Waldron J, Goldstein DP, Weinreb I, Hope AJ, Kim JJ, Chan KKW, Chan AK, Siu LL, Bernstein LJ.

JAMA Otolaryngol Head Neck Surg. 2017 Nov 22. doi: 10.1001/jamaoto.2017.2235. [Epub ahead of print]

PMID:
29167901
12.

Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment.

Beca J, Husereau D, Chan KKW, Hawkins N, Hoch JS.

Pharmacoeconomics. 2018 Jan;36(1):7-15. doi: 10.1007/s40273-017-0583-4.

PMID:
29110141
13.

Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding.

Srikanthan A, Mai H, Penner N, Amir E, Laupacis A, Sabharwal M, Chan KKW.

Curr Oncol. 2017 Oct;24(5):295-301. doi: 10.3747/co.24.3648. Epub 2017 Oct 25.

14.

Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.

Prawira A, Oosting SF, Chen TW, Delos Santos KA, Saluja R, Wang L, Siu LL, Chan KKW, Hansen AR.

Br J Cancer. 2017 Dec 5;117(12):1743-1752. doi: 10.1038/bjc.2017.357. Epub 2017 Oct 24. Review.

PMID:
29065104
15.

Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma.

Zargar M, McFarlane T, Chan KKW, Wong WWL.

Oncologist. 2017 Oct 11. pii: theoncologist.2017-0277. doi: 10.1634/theoncologist.2017-0277. [Epub ahead of print]

PMID:
29021380
16.

Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.

Thein HH, Qiao Y, Zaheen A, Jembere N, Sapisochin G, Chan KKW, Yoshida EM, Earle CC.

PLoS One. 2017 Oct 10;12(10):e0185198. doi: 10.1371/journal.pone.0185198. eCollection 2017.

17.

Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.

Leung TH, Tang HW, Siu MK, Chan DW, Chan KK, Cheung AN, Ngan HY.

J Pathol. 2018 Feb;244(2):151-163. doi: 10.1002/path.4991. Epub 2017 Dec 19.

PMID:
28944962
18.

The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.

Zhang B, Zhang Y, Zou X, Chan AW, Zhang R, Lee TK, Liu H, Lau EY, Ho NP, Lai PB, Cheung YS, To KF, Wong HK, Choy KW, Keng VW, Chow LM, Chan KK, Cheng AS, Ko BC.

J Pathol. 2017 Dec;243(4):418-430. doi: 10.1002/path.4976. Epub 2017 Oct 27.

19.

Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.

Chan KKL, Siu MKY, Jiang YX, Wang JJ, Wang Y, Leung THY, Liu SS, Cheung ANY, Ngan HYS.

BMC Cancer. 2017 Aug 31;17(1):606. doi: 10.1186/s12885-017-3601-1.

20.

Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size.

Chan KKW, Xie F, Willan AR, Pullenayegum EM.

Med Decis Making. 2018 Jan;38(1):26-33. doi: 10.1177/0272989X17725748. Epub 2017 Aug 19.

PMID:
28823185

Supplemental Content

Loading ...
Support Center